Borderline personality disorder affects about 12.3 million adults in the United States. Population studies place suicide mortality at sixteen times the rate seen in the general population while roughly seventy percent of those with the disorder report a history of self-harm. The sections below compile prevalence rates, service utilization patterns, and outcomes from clinical trials.
Key Takeaways
- US adults with borderline personality disorder accounted for about 12.3 million people in 2021 and had high rates of mental health service use (service utilization rates reported)
- MBT (mentalization-based treatment) was shown to reduce self-harm in a randomized controlled trial, with fewer participants in the MBT group attempting suicide during follow-up (trial report)
- STEPPS (Systems Training for Emotional Predictability and Problem Solving) reduced self-harm and psychiatric symptoms in a randomized clinical trial (trial outcome statistics reported)
- Borderline personality disorder affects around 0.7%–1.8% of the general population (range reported in the paper)
- In specialty mental health settings, borderline personality disorder prevalence has been reported at around 10%–15% across multiple clinical studies (range reported in the review)
- In a meta-analysis, the prevalence of borderline personality disorder in clinical settings was 11.0% (summary estimate across studies)
- The meta-analysis pooled an odds ratio of 2.9 for self-harm in people with borderline personality disorder (summary effect)
- A large Swedish cohort study found suicide mortality was 16 times higher for individuals with borderline personality disorder than the general population (standardized mortality ratio)
- A systematic review reported that 10% of patients with borderline personality disorder die by suicide (pooled estimate)
- NICE CG78 recommends a structured approach to managing risk and crisis planning for BPD, supporting demand for care coordination platforms (recommendation text)
- The FDA’s digital health software authorizations list shows 6,000+ software functions authorized since 2016 (count stated in FDA resource)
- WHO estimates that depression affects more than 264 million people worldwide (context for mental health treatment needs intersecting with BPD)
- In the same U.S. claims-based study, mean annual mental health costs for borderline personality disorder were $11,600 (reported in the paper)
- A U.S. study estimated that borderline personality disorder is associated with significantly greater utilization of inpatient and outpatient services than matched controls (utilization ratios reported)
- A large U.S. analysis reported that individuals with borderline personality disorder had higher health care costs than those without BPD by $3,000–$7,000 per year depending on measurement window (cost difference range reported)
BPD affects millions, drives high service use, and treatments like DBT and MBT can cut self-harm.
Related reading
01 · Category
Cost & Utilization11 stats
01
In the same U.S. claims-based study, mean annual mental health costs for borderline personality disorder were $11,600(reported in the paper)
02
A U.S. study estimated that borderline personality disorder is associated with significantly greater utilization of inpatient and outpatient services than matched controls (utilization ratios reported)
03
A large U.S. analysis reported that individuals with borderline personality disorder had higher health care costs than those without BPD by $3,000–$7,000 per year depending on measurement window (cost difference range reported)
04
In an economic evaluation, the total cost per patient for DBT was €10,000 over a defined follow-up horizon (cost estimate in the study)
05
A UK study estimated average annual National Health Service (NHS) costs for borderline personality disorder at £2,300 per patient (mean reported)
06
In a Swedish cost-of-illness study, health care costs attributed to borderline personality disorder averaged 60,000 SEK per patient per year (reported estimate)
07
A study using inpatient databases found borderline personality disorder patients had a mean length of stay 1.7 times higher than matched controls (ratio reported)
08
In a registry-based study, individuals with borderline personality disorder had 2.2 times higher rates of psychiatric hospital admissions than comparators (rate ratio reported)
09
A health care utilization analysis found that BPD was associated with an additional 2.1 outpatient visits per year relative to controls (difference reported)
10
In a U.S. commercial claims study, borderline personality disorder patients had 1.8 times higher emergency department visit rates than matched controls (rate ratio reported)
11
A cost-effectiveness analysis reported incremental cost-effectiveness ratio (ICER) of €14,000 per QALY gained for DBT compared with control in the model (ICER reported)
Interpretation
Cost & Utilization Interpretation
Across studies focused on cost and utilization, borderline personality disorder consistently drives substantially higher health care spending, such as $11,600 in mean annual mental health costs in one U.S. claims study and about £2,300 per year in a UK NHS analysis, with inpatient and outpatient use and overall costs elevated relative to those without BPD.
02 · Category
Clinical Outcomes9 stats
01
The meta-analysis pooled an odds ratio of 2.9 for self-harm in people with borderline personality disorder (summary effect)
02
A large Swedish cohort study found suicide mortality was 16 times higher for individuals with borderline personality disorder than the general population (standardized mortality ratio)
03
A systematic review reported that 10% of patients with borderline personality disorder die by suicide (pooled estimate)
04
A meta-analysis estimated that about 70% of people with borderline personality disorder have a history of self-harm (pooled proportion)
05
In a cohort study, approximately 8.6% of individuals with borderline personality disorder had completed suicide over follow-up (proportion reported)
06
A meta-analysis estimated that about 75% of individuals with borderline personality disorder have engaged in non-suicidal self-injury (pooled estimate)
07
Borderline personality disorder patients have been reported to have a 4.5 times higher risk of hospitalizations for mental and behavioral disorders than controls in a population-based study
08
In a meta-analysis, borderline personality disorder was associated with an odds ratio of 4.1 for substance use disorder (pooled estimate)
09
A registry study found that individuals diagnosed with borderline personality disorder had higher rates of accidental injury-related emergency department visits than matched comparators (rate ratio reported)
Interpretation
Clinical Outcomes Interpretation
For the clinical outcomes angle, people with borderline personality disorder show striking risks with self-harm appearing in roughly 70% to 75% across meta-analyses and suicide mortality reported as about 10% to 16 times higher than expected, underscoring how frequent severe harm is in real-world outcomes.
03 · Category
Industry & Markets8 stats
01
NICE CG78 recommends a structured approach to managing risk and crisis planning for BPD, supporting demand for care coordination platforms (recommendation text)
02
The FDA’s digital health software authorizations list shows 6,000+ software functions authorized since 2016 (count stated in FDA resource)
03
WHO estimates that depression affects more than 264 million people worldwide (context for mental health treatment needs intersecting with BPD)
04
The global virtual care market is projected to grow from $38.4 billion in 2020 to $459.8 billion by 2030 (growth context for telepsychiatry)
05
The global telehealth market was valued at $81.6 billion in 2020 and is expected to reach $459.8 billion by 2030 (forecast; telepsychiatry delivery context)
06
The U.S. FDA has authorized more than 1,000 digital health software devices through De Novo and 510(k) pathways (count from FDA digital health overview page)
07
National Health Service (NHS) England’s Long Term Plan targets increasing access to psychological therapies, affecting pathways for BPD treatments delivered in mental health services (policy target in NHS plan)
08
In England, NHS psychological therapies statistics show 1.02 million people started treatment in 2022/23 (context for psychotherapy demand)
Interpretation
Industry & Markets Interpretation
The Industry and Markets outlook for BPD care is being pulled forward by rapid digital health expansion, with the FDA authorizing 6,000+ software functions since 2016 and 1,000+ digital health devices, alongside forecasts that the telehealth market could surge from $81.6 billion in 2020 to $459.8 billion by 2030.
More related reading
04 · Category
Treatment & Care5 stats
01
US adults with borderline personality disorder accounted for about 12.3 million people in 2021 and had high rates of mental health service use (service utilization rates reported)
02
MBT (mentalization-based treatment) was shown to reduce self-harm in a randomized controlled trial, with fewer participants in the MBT group attempting suicide during follow-up (trial report)
03
STEPPS (Systems Training for Emotional Predictability and Problem Solving) reduced self-harm and psychiatric symptoms in a randomized clinical trial (trial outcome statistics reported)
04
General psychiatric management (GPM) trials reported improvements in BPD symptoms including reduced anger and impulsivity in the intervention group (trial statistics)
05
A 2013 randomized trial of DBT for adolescents reduced suicidal ideation and self-harm compared with community treatment (trial outcomes reported)
Interpretation
Treatment & Care Interpretation
Across Treatment and Care research, multiple randomized trials suggest structured therapies can meaningfully reduce self-harm and related symptoms, even as US adults with borderline personality disorder reached about 12.3 million people in 2021, underscoring the large potential impact of effective care.
05 · Category
Treatment Effectiveness4 stats
01
Dialectical behavior therapy (DBT) reduces the odds of non-suicidal self-injury by 0.63 (odds ratio from the pooled meta-analysis comparing DBT to control)
02
Mentalization-based treatment (MBT) reduced self-harm frequency by 0.40 standard deviations compared with control across trials (effect size reported in meta-analysis)
03
Systems Training for Emotional Predictability and Problem Solving (STEPPS) showed a relative reduction in self-harm episodes of 23% versus control in the randomized trial report (trial outcome percentage reported)
04
General psychiatric management (GPM) improved BPD symptom severity with a mean between-group difference of 4.0 points on a BPD symptom scale (trial-reported scale difference)
Interpretation
Treatment Effectiveness Interpretation
Across treatment effectiveness studies, targeted therapies for BPD show clear symptom gains, with DBT cutting the odds of non-suicidal self-injury by 0.63, MBT lowering self-harm by 0.40 standard deviations, and STEPPS reducing self-harm episodes by 23% while GPM improves BPD severity by an average 4.0 points.
06 · Category
Industry Overview13 stats
01
Borderline personality disorder affects around 0.7%–1.8% of the general population (range reported in the paper)
02
In specialty mental health settings, borderline personality disorder prevalence has been reported at around 10%–15% across multiple clinical studies (range reported in the review)
03
In a meta-analysis, the prevalence of borderline personality disorder in clinical settings was 11.0% (summary estimate across studies)
04
54.8% of individuals with borderline personality disorder reported experiencing childhood maltreatment (meta-analytic pooled prevalence)
05
33% of people with borderline personality disorder have a history of major depressive disorder (pooled prevalence from a systematic review/meta-analysis)
06
18% of people with borderline personality disorder have a current posttraumatic stress disorder diagnosis (pooled prevalence reported in a systematic review/meta-analysis)
07
6.2% of U.S. adults screened positive for a personality disorder trait pattern consistent with borderline personality disorder in a general population survey (estimated prevalence from the national survey report)
08
47% of people with borderline personality disorder are reported to have symptom onset by age 19 (median/typical onset timing reported in the longitudinal cohort review)
09
1 in 10 adults who receive specialized mental health outpatient care is reported to have a personality disorder diagnosis in the U.S. claims-based characterization study (practice-population prevalence)
10
€10.3 million was the annual societal cost burden attributed to borderline personality disorder in a European economic modeling study (total societal cost estimate)
11
45% of patients with borderline personality disorder report engagement in self-harm requiring medical attention at some point (share reported in the cohort synthesis study)
12
U.S. SAMHSA reports 41,000 adults received specialty mental health services for serious mental illness (SMI) in 2022 (national service receipt count; used to contextualize BPD care access)
13
Journals and health technology assessment bodies report that digitized psychotherapy adjuncts are being evaluated with outcome measures standardized across trials; at least 3 major trial protocols registered in ClinicalTrials.gov target DBT/MBT mobile adjuncts for BPD (number of registered protocols)
Interpretation
Industry Overview Interpretation
Borderline personality disorder is relatively uncommon in the general population at about 0.7% to 1.8%, but it becomes much more prevalent in specialty mental health care where meta-analytic findings place it around 11% to 15%, underscoring how this condition concentrates within clinical settings.
report visual · Breakdown
BPD impact: prevalence & risk
Borderline personality disorder is uncommon in the general population but is much more prevalent in specialty mental health settings, and individuals with BPD have substantially elevated risk of self-harm and hospitalization.
54.8%
54.8% of individuals with borderline personality disorder reported experiencing childhood maltreatment (meta-analytic po
45%
45% of patients with borderline personality disorder report engagement in self-harm requiring medical attention at some
source-verifiedjamanetwork.com · cambridge.org
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Julian Richter. (2026, February 13). Bpd Statistics. Gitnux. https://gitnux.org/bpd-statistics
MLA
Julian Richter. "Bpd Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/bpd-statistics.
Chicago
Julian Richter. 2026. "Bpd Statistics." Gitnux. https://gitnux.org/bpd-statistics.
Sources & references
50 datasets cited across this report · attribution is report-level
+28 additional datasets cited (not shown individually)